# Comparison of Disease Modifying Antirheumatic Drugs Therapy in Patients With RA Failing Methotrexate Monotherapy

> **NCT02930343** · PHASE3 · TERMINATED · sponsor: **Jawaharlal Institute of Postgraduate Medical Education & Research** · enrollment: 136 (actual)

## Conditions studied

- Rheumatoid Arthritis

## Interventions

- **DRUG:** Methotrexate
- **DRUG:** Leflunomide
- **DRUG:** Hydroxychloroquine
- **DRUG:** Prednisolone
- **DRUG:** Folic Acid
- **DRUG:** Sulfasalazine

## Key facts

- **NCT ID:** NCT02930343
- **Lead sponsor:** Jawaharlal Institute of Postgraduate Medical Education & Research
- **Sponsor class:** OTHER_GOV
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2016-09
- **Primary completion:** 2018-08
- **Final completion:** 2018-08
- **Target enrollment:** 136 (ACTUAL)
- **Why stopped:** Due to time constraints, the study was halted prematurely
- **Last updated:** 2021-07-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02930343

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02930343, "Comparison of Disease Modifying Antirheumatic Drugs Therapy in Patients With RA Failing Methotrexate Monotherapy". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02930343. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*